ONC Latest Headlines

BeOne Medicines Advances BG-A3004 Into First-in-Human Skin Disease Trial: What Investors Should Watch

at www.tipranks.com (Thu, 19-Mar 12:32 PM)

Bernstein Sticks to Its Buy Rating for BeOne Medicines (ONC)

at www.tipranks.com (Wed, 18-Mar 7:55 AM)

Barclays Sticks to Its Buy Rating for BeOne Medicines (ONC)

at www.tipranks.com (Wed, 18-Mar 3:35 AM)

Early Cancer Drug Trial Termination Highlights Pipeline Risk for BeOne Medicines (ONC)

at www.tipranks.com (Mon, 16-Mar 12:30 PM)

Most oversold healthcare stocks above $10B on Wall Street amid Middle East disruptions

at seekingalpha.com (Mon, 16-Mar 10:47 AM)

Analysts Offer Insights on Healthcare Companies: BeOne Medicines (ONC), Argenx Se (ARGX) and Erasca (ERAS)

at www.tipranks.com (Mon, 16-Mar 8:20 AM)

ONC Delivers Robust Revenue Growth and Pipeline Progress Amid Record Free Cash Flow

Market Chameleon (Thu, 26-Feb 8:40 AM)

Phase 3 HERIZON-GEA-01 Results Position ZIIHERA Plus TEVIMBRA and Chemotherapy as Potential New Standard for HER2+ Advanced GEA

Market Chameleon (Wed, 7-Jan 9:03 AM)

BeOne Medicines to Spotlight Global Oncology Advances at 44th J.P. Morgan Healthcare Conference

Market Chameleon (Tue, 23-Dec 8:56 AM)